Delivery Order SPE2DR25D1104-SPE2DR26FK540
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17.3K to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 11, 2025, with completion targeted for July 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract vehicle....
- The Defense Logistics Agency awarded a $28,025.95 delivery order to AmerisourceBergen Drug Corp for 30-count supplies of Biktarvy 50-200-25 mg tablets, with a completion date of December 2, 2025. This is a firm fixed-price, non-set-aside contract utilizing open competition. The pharmaceutical product will be delivered to the contractor's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $33,628.98 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of December 9, 2025, and no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $28,044.86 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The contract specifies performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This competitive, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $57,309.65. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by November 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $18,577.92, with an ultimate completion date of August 15, 2025. The contract is non-set-aside and represents a competitive award under the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $28,767.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform the work at its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $78,499.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with an ultimate completion date of July 1, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,136.57 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). The contract, which is a non-set-aside award issued through competitive procurement, requires completion by December 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK540Delivery Order
The Defense Logistics Agency awarded a $38,613.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count supplies of Biktarvy 50-200-25 mg tablets, with a completion date of December 3, 2025. This non-set-aside competitive award represents a single delivery order fulfillment under the company's broader pharmaceutical supply relationship with the federal government. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The current Biktarvy delivery exemplifies the company's role as a critical vendor for federal medical procurement, supplying both brand-name and generic pharmaceuticals to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.6k | 12/1/25 |